WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017200911) COMPOSITIONS FOR ACTIVATING MITOCHONDRIA
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2017/200911    International Application No.:    PCT/US2017/032624
Publication Date: 23.11.2017 International Filing Date: 15.05.2017
IPC:
A61K 38/54 (2006.01), A61J 1/06 (2006.01), A61K 9/48 (2006.01), A61K 31/426 (2006.01), A61K 31/70 (2006.01), A61K 47/02 (2006.01)
Applicants: LIFELINE NUTRACEUTICALS CORPORATION [US/US]; 9785 S. Monroe Street, Suite 300 Sandy, Utah 84070 (US)
Inventors: CHEVREAU, Nathalie; (US)
Agent: MUELLER, Lisa; (US).
KOLOM, Melissa; (US).
MICHAEL BEST & FRIEDRICH LLP; 444 W. Lake Street, Suite 3200 Chicago, Illinois 60606 (US)
Priority Data:
62/337,238 16.05.2016 US
Title (EN) COMPOSITIONS FOR ACTIVATING MITOCHONDRIA
(FR) COMPOSITIONS POUR ACTIVER LES MITOCHONDRIES
Abstract: front page image
(EN)Compositions including Rhodiola rosea, coenzyme Q10, grape extract, alphalipoic acid, and/or quercetin are provided. The compositions may be used for activating mitochondria in a subject. The compositions may modulate the expression of at least one of NRF1, cytochrome C, and/or TFAM in a manner that is independent of PGC-1α. Methods of using the compositions are also provided.
(FR)L'invention concerne des compositions comprenant Rhodiola rosea, la coenzyme Q 10, de l'extrait de raisin, de l'acide alphalipoïque et/ou de la quercétine. Les compositions peuvent être utilisées pour activer les mitochondries chez un sujet. Les compositions peuvent moduler l'expression d'au moins l'un parmi NRF1, cytochrome C et/ou TFAM d'une manière qui est indépendante de PGC -1 alpha. L'invention concerne également des procédés d'utilisation des compositions.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)